Abstract
Toxoplasma gondii is an apicomplexan parasite that affects both humans and livestock. Transmitted to humans through ingestion, it is the second-leading cause of foodborne illness-related death. Currently, there exists no approved vaccine for humans or most livestock against the parasite. DNA vaccines, a type of subunit vaccine which uses segments of the pathogen's DNA to generate immunity, have shown varying degrees of experimental efficacy against infection caused by the parasite. This review compiles DNA vaccine efforts against Toxoplasma gondii, segmenting the analysis by parasite antigen, as well as a review of concomitant adjuvant usage. No single antigenic group was consistently more effective within in vivo trials relative to others.
Original language | English (US) |
---|---|
Pages (from-to) | 882-903 |
Number of pages | 22 |
Journal | The Journal of parasitology |
Volume | 107 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2021 |
Keywords
- Adjuvants
- Antigens
- DNA vaccines
- Toxoplasma gondii
ASJC Scopus subject areas
- Parasitology
- Ecology, Evolution, Behavior and Systematics